CORAL GABLES, Fla., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for ...
Coral Gables, Fla.-based Catalyst Pharmaceuticals Inc. announced it has filed a suit against the U.S. Food and Drug Administration and several related parties challenging the recent approval of a new ...
Catalyst Paper Corp. (TSX:CTL) will file for creditor protection, the company announced this morning. Yesterday, the company expressed disappointment with a January 29 union vote against a collective ...
Patrick J. McEnany, Catalyst's Chief Executive Officer commented, "Our existing cash as of March 31, 2008 of $14.7 million is expected to meet our needs for the next twelve months. We have filed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback